STS Digital is a regulated principal trading firm specialized in digital-asset derivatives and providing institutional-grade market access. Clients can trade more than 400 tokens across vanilla and exotic options, spot, and structured products through a unified platform spanning UI, API, and voice channels. Built by derivatives veterans and licensed by the Bermuda Monetary Authority, STS Digital delivers deep liquidity, competitive pricing, and robust risk-management to ensure a seamless trading experience.
Status: Private
Alder
Alder offers expert, hands-on support for families navigating the complexities of aging. Alder is a team of experienced social workers and nurses helping families navigate the complexities of aging with compassion, clarity, and hands-on support.
Quarry Thera
Quarry Thera is a biotech company advancing next-generation proximity-induced therapeutics using molecular glues. Molecular glues represent a powerful new drug modality, leveraging proprietary DNA-encoded libraries, structure-based design, and advanced medicinal chemistry to overcome challenges like limited efficacy, poor permeability, and the difficulty of targeting undruggable proteins.
iRiva Medical
iRiva Medical is developing next-generation neuromodulation technology aimed at treating chronic diseases. The company focuses on addressing unmet clinical needs for large patient populations through innovative implantable medical devices.
Curvance
Curvance is a next-generation DeFi protocol that makes lending, borrowing, and earning across multiple blockchains easier and more efficient. Built for capital efficiency and composability, it lets users borrow against yield-bearing assets without giving up their returns. With features like one-click looping, risk-isolated markets, and a plugin system for smooth integrations, Curvance empowers both users and developers to get more out of DeFi.
Hercle
Hercle is an institutional liquidity infrastructure platform that enables banks, brokers, payment service providers, and other financial institutions to move large amounts of capital across borders using digital assets, stablecoins, and fiat currencies. Founded in 2019 in Milan, the company provides unified access to liquidity and settlement across 30+ digital assets and 25+ currencies. Hercle operates in compliance with European MiCA guidelines and is FINMA-authorized in Switzerland, serving more than 200 institutional customers worldwide.
Limitless.Exchange
Limitless.Exchange is a prediction market platform that makes trading crypto and stocks as simple as possible. Built on Base, Limitless offers short-term fast price markets that settle instantly with no liquidation risk or hidden fees. It enables users to trade on short-term predictions—such as whether Bitcoin, Ethereum, or major stock indices will rise above specific price thresholds within 30- or 60-minute markets—without liquidation risk or hidden fees.
Lemon
Lemon stands at the forefront of Latin America’s fintech revolution, dedicated to transforming the accessibility and everyday adoption of cryptocurrencies by merging innovative product design and dynamic community engagement. Through a mobile-first platform and products like the Lemon Card—enabling seamless crypto payments for daily life—Lemon empowers millions to participate in the digital asset economy securely and intuitively.
Kanastra
Kanastra is a Brazil-based fintech company providing end-to-end infrastructure solutions for the country’s rapidly expanding private credit market. Its platform integrates fund, securitization, and banking services — covering the full operational lifecycle — with deep automation to help originators, asset managers, and banks scale portfolios with greater transparency, efficiency, and control. Kanastra is setting the standard for how private credit infrastructure matures in Brazil and across Latin America.
Arnatar Therapeutics
Arnatar is reimagining RNA medicines to precisely silence disease drivers or restore what’s missing. Through their dual-modality DARGER™ platform, they develop best-in-class siRNA and first-in-class upregulating ASOs for cardiometabolic, liver, CNS, and kidney diseases.